{"id":"https://openalex.org/W2057710656","doi":"https://doi.org/10.1097/00004850-199112002-00004","title":"Clinical Implications of the Pharmacology of Sertraline","display_name":"Clinical Implications of the Pharmacology of Sertraline","alternate_titles":[],"publication_year":1991,"publication_date":"1991-12-01","ids":{"openalex":"https://openalex.org/W2057710656","doi":"https://doi.org/10.1097/00004850-199112002-00004","mag":"2057710656","pmid":"https://pubmed.ncbi.nlm.nih.gov/1806626"},"language":"en","primary_location":{"id":"doi:10.1097/00004850-199112002-00004","doi":"https://doi.org/10.1097/00004850-199112002-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-199112002-00004","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2057710656"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032826144","display_name":"SJ Warrington","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"S. J. WARRINGTON","raw_affiliation_strings":["Charterhouse Clinical Research Unit Limited, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charterhouse Clinical Research Unit Limited, London, UK","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5032826144"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.8736,"has_fulltext":false,"cited_by_count":128,"citation_normalized_percentile":{"value":0.968788,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"6","issue":null,"first_page":"11","last_page":"22"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9750000238418579},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9850000143051147},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.8330000042915344},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.5289999842643738},{"id":"https://openalex.org/keywords/5-hydroxytryptamine-uptake","display_name":"5-hydroxytryptamine uptake","score":0.7670000195503235},{"id":"https://openalex.org/keywords/plasma-concentration","display_name":"plasma concentration","score":0.33500000834465027},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.8849999904632568},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.609000027179718},{"id":"https://openalex.org/keywords/lithium","display_name":"lithium","score":0.7720000147819519},{"id":"https://openalex.org/keywords/hepatic-enzyme-induction","display_name":"hepatic enzyme induction","score":0.8389999866485596},{"id":"https://openalex.org/keywords/sedation","display_name":"sedation","score":0.6899999976158142},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.6069999933242798},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.9419999718666077},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.42399999499320984}],"concepts":[{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.9298782348632812},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6051363348960876},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.5655827522277832},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5549229979515076},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.527944028377533},{"id":"https://openalex.org/C2776814716","wikidata":"https://www.wikidata.org/wiki/Q574801","display_name":"Sedation","level":2,"score":0.46865975856781006},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.41918838024139404},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3228175938129425},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.08687412738800049},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009460","descriptor_name":"Neurologic Examination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011597","descriptor_name":"Psychomotor Performance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015057","descriptor_name":"1-Naphthylamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015057","descriptor_name":"1-Naphthylamine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D015057","descriptor_name":"1-Naphthylamine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D015057","descriptor_name":"1-Naphthylamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020280","descriptor_name":"Sertraline","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004850-199112002-00004","doi":"https://doi.org/10.1097/00004850-199112002-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-199112002-00004","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:1806626","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1806626","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1669455862","https://openalex.org/W2014163105","https://openalex.org/W89369262","https://openalex.org/W2003059806","https://openalex.org/W2028194357","https://openalex.org/W2035578288","https://openalex.org/W2035539260","https://openalex.org/W2079507344","https://openalex.org/W2159681206","https://openalex.org/W2004262991"],"abstract_inverted_index":{"Sertraline":[0,103,162,256,267],"is":[1,24,29,38,98,104,257,319,323],"slowly":[2],"absorbed":[3],"after":[4,45],"oral":[5,339],"administration,":[6],"with":[7,40,59,150,303,331],"peak":[8,75],"plasma":[9,76],"concentrations":[10,15,77],"at":[11,155,200],"6-8":[12],"h.":[13],"Plasma":[14],"are":[16,62,290,314],"linearly":[17],"related":[18],"to":[19,32,64,117,284,325],"dose.":[20],"The":[21,49,308],"elimination":[22,81],"half-life":[23,82],"about":[25,46],"32":[26],"h;":[27],"metabolism":[28],"by":[30],"demethylation":[31],"an":[33,179,195],"inactive":[34],"metabolite.":[35],"Once-daily":[36],"dosing":[37],"recommended,":[39],"steady":[41],"state":[42],"being":[43],"reached":[44],"7":[47],"days.":[48],"kinetics":[50],"of":[51,91,110,114,126,135,157,202,209,212,249,262,273,312],"sertraline":[52,136,239,313,322],"in":[53,57,66,85,96,107,137,141,181,197,217,299],"the":[54,115,142,210,227,271,288,300],"elderly":[55,86,221],"and":[56,80,112,147,172,238,253,306,310,342],"patients":[58,326],"renal":[60],"impairment":[61],"similar":[63],"those":[65],"young":[67,72,219],"healthy":[68,118],"female":[69],"volunteers.":[70],"In":[71],"male":[73],"volunteers,":[74],"were":[78,297],"lower,":[79],"shorter,":[83],"than":[84],"men":[87],"or":[88,160,205,220,231,329],"both":[89],"groups":[90],"women.":[92],"Nevertheless,":[93],"no":[94],"reduction":[95],"dosage":[97],"recommended":[99],"for":[100],"these":[101],"groups.":[102],"highly":[105],"active":[106],"animal":[108],"models":[109],"depression,":[111],"administration":[113],"drug":[116],"human":[119],"beings":[120],"causes":[121],"a":[122,187,246,259,279,332],"selective,":[123],"dose-related":[124],"inhibition":[125],"5-hydroxytryptamine":[127],"(5-HT)":[128],"uptake":[129],"into":[130],"blood":[131,229],"platelets.":[132],"Single":[133],"doses":[134,156,201],"volunteers":[138],"caused":[139],"changes":[140],"quantitative":[143],"pharmaco-electroencephalogram":[144],"suggesting":[145],"antidepressant":[146],"anxiolytic":[148],"actions,":[149],"sedative":[151],"potential":[152],"evident":[153],"only":[154],"200":[158],"mg":[159,204],"more.":[161,206],"does":[163,268],"not":[164,269],"impair":[165],"psychomotor":[166],"performance,":[167],"including":[168],"simulated":[169],"car":[170],"driving,":[171],"overall":[173],"seems":[174],"neither":[175],"stimulating":[176],"nor":[177],"sedating:":[178],"increase":[180,196],"critical":[182],"flicker":[183],"fusion":[184],"threshold":[185],"suggests":[186],"slight":[188],"alerting":[189],"effect,":[190],"whereas":[191],"subjective":[192],"tests":[193],"indicate":[194],"perceived":[198],"sedation":[199],"100":[203],"No":[207,223,293],"potentiation":[208],"effects":[211,225,296],"ethanol":[213],"has":[214],"been":[215,236],"noted":[216,298],"either":[218],"subjects.":[222],"adverse":[224,250],"on":[226],"electrocardiogram,":[228],"pressure,":[230],"systolic":[232],"time":[233],"intervals":[234],"have":[235],"detected,":[237],"lacks":[240],"anticholinergic":[241],"action.":[242],"These":[243],"studies":[244,302],"imply":[245],"low":[247,333],"probability":[248],"central":[251],"nervous":[252],"cardiovascular":[254],"effects.":[255],"probably":[258],"weak":[260],"inducer":[261],"hepatic":[263],"microsomal":[264],"enzyme":[265],"activity.":[266],"affect":[270],"clearance":[272],"lithium":[274,328],"but":[275],"there":[276],"may":[277],"be":[278],"pharmacodynamic":[280],"interaction":[281,301],"which":[282],"leads":[283],"increased":[285],"tremor":[286],"when":[287,321],"drugs":[289,330],"given":[291,324],"together.":[292],"clinically":[294],"relevant":[295],"digoxin,":[304],"atenolol":[305],"diazepam.":[307],"pharmacokinetics":[309],"pharmacodynamics":[311],"generally":[315],"favourable.":[316],"However,":[317],"caution":[318],"needed":[320],"receiving":[327],"therapeutic":[334],"ratio,":[335],"such":[336],"as":[337],"corticosteroids,":[338],"hypoglycaemic":[340],"agents,":[341],"warfarin.":[343]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2057710656","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
